Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1988 Jun;131(3):578–586.

Deletion of antigens of the Lewis a/b blood group family in human prostatic carcinoma.

W W Young Jr 1, S E Mills 1, M C Lippert 1, P Ahmed 1, S K Lau 1
PMCID: PMC1880693  PMID: 2454582

Abstract

The expression of antigens of the blood group Lewis a/b family were studied in a series of 42 prostatectomy specimens from patients with adenocarcinoma clinically confined to the prostate; 19 of these were later reclassified as pathologic Stage C. Staining of normal or hyperplastic versus neoplastic epithelium was assessed in routinely processed, paraffin-embedded tissue using murine monoclonal antibodies and an avidin-biotin immunoperoxidase technique. Antigens screened and the antibodies used to recognize them were Lewis a (CF4C4), Lewis b and Type 1 H (NS10), monosialosyl Lewis a I (19.9), and disialosyl Lewis a and monosialosyl Lewis a II (FH7). FH7 strongly stained the benign epithelium of all 39 Lewis positive cases, suggesting that the sialyltransferase responsible for synthesis of FH7-reactive determinants is highly active in benign prostatic tissue. When compared to the reactivity of benign epithelium in Lewis positive cases, the staining of the carcinomas was markedly reduced in 18 cases (46%) and absent in 16 cases (41%). This reduction or loss of staining of the malignant epithelium was observed for all antibodies that stained the corresponding benign epithelium of each case. In only five of the cases (13%) was the intensity of staining in the carcinoma equal to that of the surrounding benign epithelium. No cases in this latter group had recurrence of disease, whereas in the other staining groups 25-33% of the cases had recurrences; median follow-up for the entire group was 78 months. No correlation was apparent between Gleason score and the staining pattern with these antigens. In summary, antigens of the Lewis a/b family are deleted in a high percentage of cases of prostatic adenocarcinoma.

Full text

PDF
578

Images in this article

582Figure 2
on p.582
583Figure 3
on p.583
583Figure 4
on p.583
584Figure 5
on p.584
584Figure 6
on p.584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björk S., Breimer M. E., Hansson G. C., Karlsson K. A., Leffler H. Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem. 1987 May 15;262(14):6758–6765. [PubMed] [Google Scholar]
  2. Brockhaus M., Magnani J. L., Blaszczyk M., Steplewski Z., Koprowski H., Karlsson K. A., Larson G., Ginsburg V. Monoclonal antibodies directed against the human Leb blood group antigen. J Biol Chem. 1981 Dec 25;256(24):13223–13225. [PubMed] [Google Scholar]
  3. Coon J. S., Weinstein R. S. Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol. 1986 Nov;17(11):1089–1106. doi: 10.1016/s0046-8177(86)80413-0. [DOI] [PubMed] [Google Scholar]
  4. Ernst C., Atkinson B., Wysocka M., Blaszczyk M., Herlyn M., Sears H., Steplewski Z., Koprowski H. Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab Invest. 1984 Apr;50(4):394–400. [PubMed] [Google Scholar]
  5. Fowler J. E., Jr, Mills S. E. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival. J Urol. 1985 Jan;133(1):49–52. doi: 10.1016/s0022-5347(17)48778-7. [DOI] [PubMed] [Google Scholar]
  6. Ghazizadeh M., Kagawa S., Takigawa H., Kurokawa K., Numoto S. Specific red cell adherence test in benign and malignant lesions of the prostate. Br J Urol. 1983 Aug;55(4):405–407. doi: 10.1111/j.1464-410x.1983.tb03332.x. [DOI] [PubMed] [Google Scholar]
  7. Gupta R. K., Schuster R., Christian W. D. Loss of isoantigens A, B and H in prostate. Am J Pathol. 1973 Mar;70(3):439–447. [PMC free article] [PubMed] [Google Scholar]
  8. Gutman A. B., Gutman E. B. AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND. J Clin Invest. 1938 Jul;17(4):473–478. doi: 10.1172/JCI100974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 1985 Jun;45(6):2405–2414. [PubMed] [Google Scholar]
  10. Hanisch F. G., Uhlenbruck G., Dienst C. Structure of tumor-associated carbohydrate antigen Ca 19-9 on human seminal-plasma glycoproteins from healthy donors. Eur J Biochem. 1984 Nov 2;144(3):467–473. doi: 10.1111/j.1432-1033.1984.tb08489.x. [DOI] [PubMed] [Google Scholar]
  11. Hansson G. C., Karlsson K. A., Larson G., McKibbin J. M., Blaszczyk M., Herlyn M., Steplewski Z., Koprowski H. Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. J Biol Chem. 1983 Apr 10;258(7):4091–4097. [PubMed] [Google Scholar]
  12. Hansson G. C., Zopf D. Biosynthesis of the cancer-associated sialyl-Lea antigen. J Biol Chem. 1985 Aug 5;260(16):9388–9392. [PubMed] [Google Scholar]
  13. Houghton A. N., Mintzer D., Cordon-Cardo C., Welt S., Fliegel B., Vadhan S., Carswell E., Melamed M. R., Oettgen H. F., Old L. J. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1242–1246. doi: 10.1073/pnas.82.4.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hsu S. M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981 May;75(5):734–738. doi: 10.1093/ajcp/75.5.734. [DOI] [PubMed] [Google Scholar]
  15. Irie R. F., Morton D. L. Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8694–8698. doi: 10.1073/pnas.83.22.8694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Juhl B. R., Hartzen S. H., Hainau B. Lewis a antigen in transitional cell tumors of the urinary bladder. Cancer. 1986 Jul 15;58(2):222–228. doi: 10.1002/1097-0142(19860715)58:2<222::aid-cncr2820580204>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  17. Lemieux R. U., Baker D. A., Weinstein W. M., Switzer C. M. Artificial antigens. Antibody preparations for the localization of Lewis determinants in tissues. Biochemistry. 1981 Jan 6;20(1):199–205. doi: 10.1021/bi00504a033. [DOI] [PubMed] [Google Scholar]
  18. Limas C. Detection of urothelial Lewis antigens with monoclonal antibodies. Am J Pathol. 1986 Dec;125(3):515–523. [PMC free article] [PubMed] [Google Scholar]
  19. Limas C., Lange P. H. Lewis antigens in normal and neoplastic urothelium. Am J Pathol. 1985 Oct;121(1):176–183. [PMC free article] [PubMed] [Google Scholar]
  20. Magnani J. L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem. 1982 Dec 10;257(23):14365–14369. [PubMed] [Google Scholar]
  21. Nudelman E., Fukushi Y., Levery S. B., Higuchi T., Hakomori S. Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J Biol Chem. 1986 Apr 25;261(12):5487–5495. [PubMed] [Google Scholar]
  22. Szulman A. E., Marcus D. M. The histologic distribution of the blood group substances in man as disclosed by immunofluorescence. VI. The Le and Le antigens during fetal development. Lab Invest. 1973 May;28(5):565–574. [PubMed] [Google Scholar]
  23. Vowden P., Lowe A. D., Lennox E. S., Bleehen N. M. Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen. Br J Cancer. 1986 Mar;53(3):307–312. doi: 10.1038/bjc.1986.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Walker P. D., Karnik S., deKernion J. B., Pramberg J. C. Cell surface blood group antigens in prostatic carcinoma. Am J Clin Pathol. 1984 Apr;81(4):503–506. doi: 10.1093/ajcp/81.4.503. [DOI] [PubMed] [Google Scholar]
  25. Young W. W., Jr, Hakomori S. I. Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo. Science. 1981 Jan 30;211(4481):487–489. doi: 10.1126/science.7455688. [DOI] [PubMed] [Google Scholar]
  26. Young W. W., Jr, Johnson H. S., Tamura Y., Karlsson K. A., Larson G., Parker J. M., Khare D. P., Spohr U., Baker D. A., Hindsgaul O. Characterization of monoclonal antibodies specific for the Lewis a human blood group determinant. J Biol Chem. 1983 Apr 25;258(8):4890–4894. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES